Ace Therapeutics | Stroke Research Service Provider

Drug Development for Stroke

Stroke Research Service Provider

Ace Therapeutics coordinates global resources to provide biopharmaceutical companies of all sizes a proven, flexible approach to early stroke drug development. Facilitating successful development of your stroke therapies.

Make Creative Scientific Discovery

We are committed to being your trusted partner in stroke drug development. From basic research to the development of novel therapies and diagnostics technologies, we help your preclinical stroke program achieve promising results.

WELCOME TO ACE THERAPEUTICS

We Are the Leading Provider of Stroke Research Services

Ace Therapeutics is a global leading provider of stroke research services. We specialize in comprehensive stroke drug development, offering services from target discovery to preclinical evaluation. Our expertise is complemented by strong capabilities and cutting-edge technologies specifically tailored to stroke.

Our goal is to help pharmaceutical companies complete their research programs faster and more successfully, and find effective therapies for stroke.

OUR SERVICES

Pharmaceutical R&D for Stroke

Ace Therapeutics is committed to the preclinical phase of stroke drug development, covering everything from model construction, target identification to preclinical candidates and beyond with the flexibility required. We offer a broad portfolio of services and a global network of partners that enable us to provide end-to-end services for small molecule and biomolecule drug discovery in stroke.

Customized Stroke Models Ace Therapeutics has extensive experience in stroke modeling and offers a wide range of high-quality and customized animal and in vitro models of stroke designed for mechanistic studies and for testing new thrombolytic and neuroprotective strategies. In Vitro Oxygen-Glucose Deprivation-Induced Stroke Models 3D In Vitro Model of Ischemic Stroke Middle Cerebral Artery Occlusion (MCAO) Models ET-1 Induced MCAO Model for Ischemic Stroke Photothrombotic Stroke Model Embolic Stroke Models Collagenase Model of Intracerebral Hemorrhage View More
Pathogenic Mechanism Analysis Through our comprehensive analysis, we aim to help our clients improve their understanding of stroke pathophysiology, identify potential therapeutic targets for intervention, and develop stroke drugs that target different pathways of brain injury. View More
Stroke Drug Development Services Ace Therapeutics is committed to assisting clients in the development of different types of stroke drugs. Your stroke drug discovery program can move forward with reliable data and insights provided by our team of experts. View More
Preclinical Evaluation Services Our preclinical testing services support your preclinical development from target discovery to IND, covering a wide range of studies designed to evaluate the safety and efficacy of your stroke drugs. View More
Stroke Biomarker Development Services Our biomarker discovery service enables clients to explore stroke biomarkers for monitoring disease progression, therapeutic response, and potential toxicity. By integrating biomarker discovery into stroke drug development, we can accelerate the development of novel therapies. View More

THERAPEUTIC AREAS

Explore Our Expertise in Preclinical Stroke Research

At Ace Therapeutics, we are dedicated to pushing the boundaries of scientific research and supporting drug development in multiple therapeutic areas within the field of preclinical stroke research.

Ischemic Stroke Research Services

We provide customized models, target identification, and drug efficacy assessment for ischemic stroke research to improve the understanding of the pathomechanisms of ischemic stroke and the development of therapeutics.

Thrombotic stroke
Embolic stroke
Cardioembolic stroke
Cryptogenic stroke

Hemorrhagic Stroke Research Services

Our approach facilitates the detection of subtle responses in animal models, offering valuable insights into the efficacy and safety of new therapeutics for hemorrhagic stroke.

Intracerebral hemorrhage
Subarachnoid hemorrhage

Transient Ischemic Attack (TIA) Research Services

Ace Therapeutics is equipped with advanced facilities and resources to support TIA research projects. We provide highly predictive TIA models, carefully executed assessments, and detailed observational measurements to determine the effects of novel therapeutics for TIA.

WHY CHOOSE US

Grow Your Research With Experience

Ace Therapeutics has a proven, full-service model that has been delivering quality results for years, giving your stroke trial a competitive edge. The Ace Therapeutics team supports the development of therapeutics for the treatment of stroke through the use of our in-house resources including:

Professionals

Deep expertise and experience in vascular research and development.

Customization

Flexible approach with easy access to our global network of specialized laboratories. State-of-the-art technology provides you with a fully customized service.

Well-equipped

Our fully equipped laboratories have comprehensive capabilities from initial screening to candidate selection.

After Sales Service

Solving any problems or concerns that customers may have and ensuring the proper functioning of the product or service.

Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.

Quick Links

Home Services Solutions

Resources About us Contact us Careers